惊惶
发表于 2025-3-26 21:03:20
https://doi.org/10.1007/978-3-662-02086-9onic liver disease. Nonalcoholic fatty liver disease is characterized by a wide spectrum of conditions and covers a histological spectrum ranging from simple steatosis to nonalcoholic steatohepatitis (NASH), advanced fibrosis, and cirrhosis..Liver biopsy remains the gold standard for characterizing
Bereavement
发表于 2025-3-27 05:06:53
http://reply.papertrans.cn/19/1879/187817/187817_32.png
极力证明
发表于 2025-3-27 08:24:24
http://reply.papertrans.cn/19/1879/187817/187817_33.png
innovation
发表于 2025-3-27 12:48:34
http://reply.papertrans.cn/19/1879/187817/187817_34.png
Forsake
发表于 2025-3-27 15:40:53
http://reply.papertrans.cn/19/1879/187817/187817_35.png
Stricture
发表于 2025-3-27 20:07:31
http://reply.papertrans.cn/19/1879/187817/187817_36.png
精密
发表于 2025-3-27 23:59:39
http://reply.papertrans.cn/19/1879/187817/187817_37.png
semble
发表于 2025-3-28 06:05:05
http://reply.papertrans.cn/19/1879/187817/187817_38.png
lambaste
发表于 2025-3-28 07:33:24
Biomarkers of Extracellular Matrix Remodeling in Liver Diseases,modeling leads to a range of formation and disease-relevant degradation products of extracellular and intracellular proteins into the circulation. These fragments may provide information about the pathogenesis of disease and serve as serological biomarker targets. Clinically there is a need to ident
emulsify
发表于 2025-3-28 10:57:59
Biomarkers of the Antioxidant Response: A Focus on Liver Carcinogenesis,mma-glutamyl transferase (GGT), glucose-6-phosphate dehydrogenase (G6PD), thioredoxin reductase (TXNR), NAD(P)H dehydrogenase 1 (NQO1), and prostaglandin reductase 1 (PTGR1). The increased expression of these enzymes is suggested as biomarker that favors tumor development by stimulating pr